Full-Time

Sales Manager

Posted on 10/8/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$140k - $180kAnnually

Senior

United States

Field-based position in the West Region.

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Requirements
  • Bachelor’s degree in business, marketing, or a related field.
  • Minimum of 5+ years of sales experience in the pharmaceutical or biotech industry
  • 2+ years of experience in a leadership or sales management role.
  • 2+ years of experience in cardiometabolic and/or rare disease sales.
  • Demonstrated success in developing and leading high-performing teams, meeting or exceeding sales targets, and driving territory growth.
  • Experience with product launches and a deep understanding of the regional healthcare market.
  • Strong communication, leadership, and strategic thinking skills.
  • Must live within a reasonable distance of a major airport to ensure ease of travel for work-related assignments
  • Willingness and ability to travel frequently
Responsibilities
  • Lead and Manage Regional Sales Team
  • Recruit, train, and manage a team of Sales Representatives to achieve and exceed sales targets.
  • Provide ongoing coaching and performance feedback, fostering a culture of motivation and accountability.
  • Conduct regular field visits and lead sales team meetings to ensure alignment with strategic goals.
  • Implement and Execute Regional Sales Strategies
  • Develop and execute regional business plans, ensuring alignment with national goals and strategic initiatives.
  • Monitor sales performance against established targets and adjust strategies as needed to ensure success.
  • Ensure efficient resource allocation within the region to meet business objectives and maximize sales impact.
  • Build and Maintain Stakeholder Relationships
  • Build and maintain strong relationships with key external stakeholders, including healthcare professionals, payers, and other relevant partners within the region.
  • Cultivate a culture of compliance, ensuring adherence to corporate policies, procedures, and all legal and regulatory standards.
  • Maintain high training standards for the field team.
  • Foster a Culture of Compliance
  • Ensure adherence to corporate policies, regulatory guidelines, and industry best practices across the regional sales team.
  • Implement training and development programs that emphasize compliance and ethical selling practices
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases. Their approach involves a variety of RNA chemistries and effective delivery methods, allowing for significant and lasting reductions in target gene activity. Arrowhead focuses on conditions like cystic fibrosis and hepatitis B, and operates in the pharmaceutical and biotechnology markets, serving healthcare providers and patients. Unlike many competitors, Arrowhead emphasizes RNAi-based therapies, which can address medical needs that existing treatments do not meet. The company's goal is to provide new treatment options for serious genetic disorders through drug discovery and development.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead secured a $500 million facility with Sixth Street for pipeline advancement.
  • Positive Phase 2 data for plozasiran shows promise in treating severe hypertriglyceridemia.
  • Collaboration with Sarepta Therapeutics brings significant financial and research benefits.

What critics are saying

  • Increased competition from companies like Alnylam Pharmaceuticals in the RNAi space.
  • Potential regulatory scrutiny could delay clinical trials for RNAi therapies.
  • Financial instability risk due to reliance on strategic financing agreements.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its research and development capabilities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE